PAPER Manook A, Yousefi BH, Willuweit A, Platzer S, Reder S, Voss A, Huisman M, Settles M, Neff F, Velden J, Schoor M, von der Kammer H, Wester HJ, Schwaiger M, Henriksen G, Drzezga A
SEARCH RESULTS
331007 RESULTS
PAPER Jóźwik A, Landowski J, Bidzan L, Fülop T, Bryl E, Witkowski JM
Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly.
PLoS One. 2012;7(3):e33276. PubMed: 22428008PAPER Goldberg I, Auriel E, Russell D, Korczyn AD
Microembolism, silent brain infarcts and dementia.
J Neurol Sci. 2012 Mar 17; PubMed: 22429666PAPER Murray PS, Kirkwood CM, Gray MC, Ikonomovic MD, Paljug WR, Abrahamson EE, Henteleff RA, Hamilton RL, Kofler JK, Klunk WE, Lopez OL, Penzes P, Sweet RA
β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis.
Neurobiol Aging. 2012 Mar 17; PubMed: 22429885PAPER
Alzheimer disease: Epigenetic modifications could promote cognitive decline in Alzheimer disease.
J Gerontol A Biol Sci Med Sci. 2009 Dec;64(12):1275-82. PubMed: 22430103PAPER Bernick C, Cummings J, Raman R, Sun X, Aisen P
Age and Rate of Cognitive Decline in Alzheimer Disease: Implications for Clinical Trials.
Arch Neurol. 2012 Mar 19; PubMed: 22431834PAPER Le Pera M, Urso E, Sprovieri T, Bossio S, Aguglia U, Manna I, Cupidi C, Ferraro T, Gambardella A, Qualtieri A, Quattrone A
Contribution of Cerebrospinal Fluid Thymosin β4 Levels to the Clinical Differentiation of Creutzfeldt-Jakob Disease.
Arch Neurol. 2012 Mar 19; PubMed: 22431836PAPER Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P,